WOSCI Author Services

今天，我们来看看这本SCI期刊：Cellular & Molecular Immunology。从现有的记录来看，Cellular & Molecular Immunology 的2021年影响因子(JCR2020)是11.530，2020年是8.484，比2020年增长3.046，增长比例35.90%。

关于此刊的具体情况，大家可以看看：

Cellular & Molecular Immunology 的收稿范围，期刊是如此介绍的(截取部分内容)，详情请阅读：

https://www.nature.com/cmi/aims

Cellular & Molecular Immunologyis a monthly journal from the Chinese Society of Immunology and the University of Science and Technology of China. Covering both basic immunology research and clinical applications,Cellular & Molecular Immunologyprovides the latest information and advancements in our understanding of the immunological response of the host, bothin vitroandin vivo.

The journal publishes Articles, Review Articles, Mini Reviews and Short Communications and Correspondences in all areas of cellular and molecular immunology, including but not limited to:

clinical immunology

comparative immunology

immunobiology

immunogenetics

immunological techniques

immunopathology

immunopharmacology

infection immunology

neuroimmunology

transplantation immunology

tumor immunology

veterinary immunology

• Received: 24 March 2022, Accepted: 2 April 2022

• Received: 12 September 2021, Accepted: 8 December 2021

• Received: 30 August 2021, Accepted: 15 November 2021

• Received: 1 October 2021, Accepted: 20 March 2022

   

影响因子

即时影响因子计算发现，2022年5月27日，22.064分。按照常规期刊计算方法，以及往年经验，在2022年6月份公布的IF中，它或许在22分左右！期待6月份新IF的公布！

如果还没有注册过账户，只需点击“Register for an account”注册账户即可！

有11+分以上发表要求的，来看看这个潜力股的SCI期刊吧！

版权声明：本文转自“51选刊”，文章转载只为学术传播，不代表本号观点，无商业用途，版权归原作者所有，如涉及侵权问题，请联系我们，我们将及时修改或删除。